Study of Two Doses of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Trial Profile

Study of Two Doses of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Feb 2015

At a glance

  • Drugs Beclometasone (Primary)
  • Indications Grass pollen hypersensitivity; Seasonal allergic rhinitis; Tree pollen hypersensitivity
  • Focus Registrational; Therapeutic Use
  • Sponsors Teva Branded Pharmaceutical Products R&D
  • Most Recent Events

    • 23 Feb 2015 Results presented at the 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology, according to Teva Pharmaceutical Industries media release.
    • 09 Nov 2012 Results were presented at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in November 2012.
    • 06 Mar 2012 Results presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top